Dr. Amanda J. Wheeler is a board certified surgeon who specializes in the surgical management of breast disease.

She completed her general surgical residency at Stanford University. To further her career in the treatment of breast cancer she was awarded a Surgical Society of Oncology accredited fellowship in Breast Surgical Oncology at the Harvard affiliated hospitals; Dana Farber Cancer Institute, Brigham and Women’s Hospital and Massachusetts General Hospital. She is actively involved in clinical research and serves on the Education Committee for the American Society of Breast Surgeons. Her published research includes; the impact of screening mammography on the morbidity and mortality of breast cancer, utilization of breast MRI, the link between obesity and breast cancer and risk factors among the African American population for breast cancer. She has also written multiple chapters in leading textbooks and collaborated with other nationally recognized experts at MD Anderson, Memorial Sloan Kettering, Stanford University and Harvard University.

Dr. Wheeler previously was the Medical Director of the Meridian Park Legacy Breast Cancer Program and was in private practice in Portland, Oregon for five years before returning to Stanford. She enjoys playing golf, painting and yoga.

Clinical Focus

  • Cancer > Breast Cancer
  • General Surgery
  • oncoplastic surgery
  • hi risk breast cancer
  • young women with breast cancer

Academic Appointments

Administrative Appointments

  • Education Committee, American Society of Breast Surgeons (2009 - Present)

Boards, Advisory Committees, Professional Organizations

  • Member, American Society of Breast Surgeons (2009 - Present)
  • Member, American Society of Breast Diseases (2009 - Present)
  • Member, American Society of Clinical Oncology (2009 - Present)
  • Member, American College of Surgeons (2008 - Present)

Professional Education

  • Fellowship, Harvard Cancer Institute: MGH, BWH, Dana Farber Cancer Institute, Breast Surgical Oncology (2009)
  • Board Certification: General Surgery, American Board of Surgery (2008)
  • Residency:Stanford Hospital and Clinics - Dept of Surgery (2008) CA
  • Internship:Maricopa Medical Center (2003) AZ
  • Medical Education:Oregon Health Science University (2002) OR
  • Fellowship:MGH Institute of Health Professions (2009) MA


Journal Articles

  • The diagnostic value of nipple discharge cytology: Breast imaging complements predictive value of nipple discharge cytology JOURNAL OF SURGICAL ONCOLOGY Kalu, O. N., Chow, C., Wheeler, A., Kong, C., Wapnir, I. 2012; 106 (4): 381-385


    Papilloma is the most common finding associated with pathologic nipple discharge. In the absence of breast imaging abnormalities, the incidence of occult malignancy is <3%.To determine the predictive value of nipple discharge cytology in conjunction with breast imaging.Retrospective review of 160 charts; inclusion criteria of clinically pathologic nipple discharge, subsequent excisional biopsy, and absence of palpable abnormalities. Nipple discharge cytology categorized as negative, atypical, suspicious, and papillary. Breast imaging was analyzed. Preoperative tests were correlated to final surgical pathology.89 patients identified. Sixty-five had positive cytology, with a false positive rate of 32.3%. They were associated with papillomas in 52%, benign non-papillary in 33% and malignant lesions in 9% of cases. Nipple discharge cytology was positive in 69.6% of papillomas and 92% of atypical/malignant lesions; 30% had abnormal breast imaging and positive cytology. Nipple discharge cytology had a sensitivity of 74.5%, specificity of 30%, and positive predictive value of 68%. The positive predictive value increased to 85% with associated abnormal breast imaging.Nipple discharge cytology is useful in evaluating pathologic discharge. However, negative cytology with negative imaging is not enough to avoid surgery in cases of suspicious clinical presentation.

    View details for DOI 10.1002/jso.23091

    View details for Web of Science ID 000307550900005

    View details for PubMedID 22396104

  • Metastases to the breast: Alveolar soft part sarcoma in adolescents CLINICAL BREAST CANCER Madrigrano, A., Beach, B., Wheeler, A., Wapnir, I. 2008; 8 (1): 92-93


    Metastases to the breast comprise 0.5%-2% of breast neoplasms. This is a case report of an 18-year-old woman with an alveolar soft part sarcoma metastatic to the breast.

    View details for Web of Science ID 000253503000010

    View details for PubMedID 18501064

Stanford Medicine Resources: